Cargando…
Myocardial fibrosis: biomedical research from bench to bedside
Myocardial fibrosis refers to a variety of quantitative and qualitative changes in the interstitial myocardial collagen network that occur in response to cardiac ischaemic insults, systemic diseases, drugs, or any other harmful stimulus affecting the circulatory system or the heart itself. Myocardia...
Autores principales: | Gyöngyösi, Mariann, Winkler, Johannes, Ramos, Isbaal, Do, Quoc‐Tuan, Firat, Hüseyin, McDonald, Kenneth, González, Arantxa, Thum, Thomas, Díez, Javier, Jaisser, Frédéric, Pizard, Anne, Zannad, Faiez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299507/ https://www.ncbi.nlm.nih.gov/pubmed/28157267 http://dx.doi.org/10.1002/ejhf.696 |
Ejemplares similares
-
Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis
por: Ferreira, João Pedro, et al.
Publicado: (2017) -
Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension
por: Gyöngyösi, Mariann, et al.
Publicado: (2017) -
Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models
por: Bonnard, Benjamin, et al.
Publicado: (2021) -
Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis
por: Lukovic, Dominika, et al.
Publicado: (2023) -
Biomedical Advances in ABCA1 Transporter: From Bench to Bedside
por: Choi, Hong Y., et al.
Publicado: (2023)